Physician
Family Medicine
Dr. Todd E. Fox, MD
|
|
Give Review
Todd is an expert in the field of Family Medicine. He researched medicine at University of Kansas School of Medicine. He has 2 awards "Patient-Centered Medical Home Recognition Program" and "CMS Meaningful Use Stage 1 Certification". Todd E. Fox, MD is a published doctor and has 29 publications published. The lastest was: 'Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia-Impact on enzyme activity and response to cytotoxics.' Doctor Todd E. Fox, MD is registered with Medicare and accepts Medicare payments.
Publications
- The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines.
- Lysosomal Degradation of CD44 Mediates Ceramide Nanoliposome-induced Anoikis and Diminished Extravasation in Metastatic Carcinoma Cells.
- Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia-Impact on enzyme activity and response to cytotoxics.
- Novel off-target effect of tamoxifen - Inhibition of acid ceramidase activity in cancer cells.
- PhotoImmunoNanoTherapy Reveals an Anticancer Role for Sphingosine Kinase 2 and Dihydrosphingosine-1-Phosphate.
- Nanoliposomal minocycline for ocular drug delivery.
- Targeting Sphingosine Kinase-1 To Inhibit Melanoma.
- Exogenous ceramide-1-phosphate reduces LPS-mediated cytokine expression.
- Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.
- Transcriptional regulation of the human neutral ceramidase gene.
- AP-1 binding transcriptionally regulates human neutral ceramidase.
- Circulating sphingolipid biomarkers in models of type 1 diabetes.
- Insulin signaling in retinal neurons is regulated within cholesterol-enriched membrane microdomains.
- Dysregulation of sphingolipid metabolism in cancer.
- Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy.
- Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance.
- Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.
- Ceramide modulates HERG potassium channel gating by translocation into lipid rafts.
- Use of high performance liquid chromatography-electrospray ionization-tandem mass spectrometry for the analysis of ceramide-1-phosphate levels.
- Therapeutic strategies for diabetes and complications: a role for sphingolipids?
- Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition.
- Propagation of undifferentiated human embryonic stem cells with nano-liposomal ceramide.
- Optimized expression and purification of myristoylated human neuronal calcium sensor 1 in E. coli.
- Ether-linked diglycerides inhibit vascular smooth muscle cell growth via decreased MAPK and PI3K/Akt signaling.
- C(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured Arteries.
- Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains.
- Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy.
- C6-ceramide nanoliposomes target the warburg effect in chronic lymphocytic leukemia.
Schools
University of Kansas School of Medicine
University Kans
University KansKans University Med Center
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Preferred Care Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Coventry Health Care of Kansas, Inc. PPO
- Coventry Health Care of Missouri PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Preferred PPO
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- PHP-Physicians Health Plan
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Patient-Centered Medical Home Recognition Program
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Kansas School of Medicine
Hospital
-
North Kansas City Hospital
Drug Facts
| NPI NUMBER | 1700856358 | |
| NPPES Provider LastName | FOX | |
| NPPES Provider FirstName | TODD | |
| NPPES Provider ZIPCode | 641552262 | |
| NPPES Provider State | MO | |
| Specialty Description | Family Practice | |
| Total Claim Count | 3521.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 176.0 | |
| Percent Opioid Claims | 5.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700856358 |
| Last Name Of The Provider | FOX |
| First Name Of The Provider | TODD |
| View All |
Similar Doctors
|
|
Dr. Elaine W. Joslyn, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Lucas Thompson, MD |
|
|
Dr. Karladine E. Graves, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norma E. Green, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven R. Warlick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry M. Silvers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bridgett A. Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martha A. Duffin, DO |